Optimized Bioresorbable Scaffold Implantation: From PSP to CIAO and Back to Facts
- PMID: 34247984
- DOI: 10.1016/j.carrev.2021.06.113
Optimized Bioresorbable Scaffold Implantation: From PSP to CIAO and Back to Facts
Conflict of interest statement
Declaration of competing interest M.S. reports no conflict of interest; M.J. reports personal fees from Orbus Neich, Astra Zeneca, Recor, grants and personal fees from Biotronik, Boston Scientific, Edwards Lifesciences and grant support from Amgen outside the submitted work. MJ has received funding from the German Center for Cardiovascular Research: DZHK (FKZ 81Z0600502; FKZ 81X2600526) and from the Leducq Foundation (grant agreement number 18CVD02).
Comment on
-
ImpaCt of an Optimal Implantation Strategy on Absorb Long-Term Outcomes: The CIAO Registry.Cardiovasc Revasc Med. 2021 Sep;30:1-8. doi: 10.1016/j.carrev.2020.09.036. Epub 2020 Oct 1. Cardiovasc Revasc Med. 2021. PMID: 33077393
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous